Navigation Links
STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences
Date:8/7/2014

MONROVIA, Calif., Aug. 7, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the following investor conferences:

The Wedbush 2014 Life Sciences Management Access Conference at the Le Parker Meridien Hotel in New York on Tuesday, August 12 at 10:20 a.m. PT/1:20 p.m. ET

The Canaccord Genuity 34th Annual Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 10:00 a.m. PT/1:00 p.m. ET

Barry Caldwell, President and CEO, Hans Blickensdoerfer, President, Europe, Middle East, Latin America, and Steve Brown, CFO will offer a general overview of the Company's current business trends, recent financial results, and operational developments. A live webcast, including accompanying slides, will be available from the Company's website, under Investor Information. An archived replay of management's presentations will be available for 90 days following the event, also at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:InvestorsMediaEVC Group

EVC GroupDoug Sherk

Nicole Kruse 415-652-9100

646-688-0425


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports 10% Second Quarter Revenue Growth
2. STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31
3. STAAR Surgical Announces Second Quarter 2014 Results Release Date, Conference Call And Webcast
4. STAAR Surgical To Present At Piper Jaffray Healthcare Investor Conference
5. STAAR Surgical to Host Investor Breakfast and Webcast during the American Academy of Ophthalmologys Annual Meeting
6. STAAR Surgical Reports Continued Momentum During Third Quarter
7. STAAR Surgical Reports Strong Second Quarter Financial Results
8. STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast
9. STAAR Surgical To Present At Upcoming Investor Conferences
10. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
11. STAAR Surgical Provides Preliminary First Quarter Revenue Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... "FCPX editors can now reveal their media with growing colorful split ... Austin - CEO of Pixel Film Studios. , ProSlice Color brings the split ... now reveal the media of their split screens with growing colorful panels. , ProSlice ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):